Vnitr Lek 2008, 54(11):1100-1101

Hypoglycaemic periodic paralysis in hyperthyroidism patients

J. Kratochvíl*, J. Masopust, V. Martínková, J. Charvát
Jednotka intenzivní metabolické péče Interní kliniky 2. lékařské fakulty UK a FN Motol Praha, přednosta prof. MUDr. Milan Kvapil, CSc., MBA

Hypokalemic periodic paralysis (HPP) is a rare disorder characterised by acute, potentially fatal atacks of muscle weakness or paralysis. Massive shift of potassium into cells is caused by elevated levels of insulin and catecholamines in the blood. Hypophosphatemia and hypomagnesemia may be also present. Acidobasic status usually is not impaired. HPP occurs as familiar (caused by ion channels inherited defects) or acquired (in patients with hyperthyroidism). On the basis of two clinical cases we present a review of hypokalemic periodic paralysis in hyperthyroid patients. We discuss patogenesis, clinical and laboratory findings as well as the principles of prevention and treatment of this rare disorder.

Keywords: hyperthyroidism; hypokalemia; hypokalemic periodic paralysis

Received: February 21, 2008; Accepted: July 8, 2008; Published: November 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kratochvíl J, Masopust J, Martínková V, Charvát J. Hypoglycaemic periodic paralysis in hyperthyroidism patients. Vnitr Lek. 2008;54(11):1100-1101.
Download citation

References

  1. Fontaine B et al. Periodic paralysis and voltage-gated ion channels. Kidney Int 1996; 49: 9-18. Go to original source... Go to PubMed...
  2. Ober KP. Thyrotoxic periodic paralysis in the United States. Report of seven cases and review of the literature. Medicine (Baltimore) 1992; 71: 109. Go to original source... Go to PubMed...
  3. Manoukian MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 1999; 159: 601-606. Go to original source... Go to PubMed...
  4. Kung AW et al. Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab 2004; 89: 1340-1345. Go to original source... Go to PubMed...
  5. Ptacek LJ et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994; 77: 863-868. Go to original source... Go to PubMed...
  6. Wang Q et al. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family. J Mol Med 2005; 83: 203-208. Go to original source... Go to PubMed...
  7. Sternberg D et al. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 2001; 124: 1091. Go to original source... Go to PubMed...
  8. Ko GT et al. Thyrotoxic periodic paralysis in a Chinese population. QJM 1996; 89: 463-468. Go to original source... Go to PubMed...
  9. Chan A et al. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ 1991; 303: 1096-1099. Go to original source... Go to PubMed...
  10. Wu CC et al. An unrecognized cause of paralysis in ED: thyrotoxic normokalemic periodic paralysis. Am J Emerg Med 2003; 21: 71-73. Go to original source... Go to PubMed...
  11. Kim JB, Lee KY, Hur JK A. Korean family of hypokalemic periodic paralysis with mutation in a voltage-gated calcium channel (R1239G). J Korean Med Sci 2005; 20: 162-165. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.